Jennison Associates’s IDEAYA Biosciences IDYA Stock Holding History

Jennison Associates’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.26M	Sell	248,559 -7,205	-3%	-$221K	0.01%	402
2026 Q1	$8.52M	Buy	+255,764	New	+$8.58M	0.01%	398
2025 Q2	–	Sell	-526,688	Closed	-$8.63M	–	608
2025 Q1	$8.63M	Sell	526,688 -447,948	-46%	-$9.54M	0.01%	388
2024 Q4	$25M	Buy	974,636 +2,370	+0.2%	+$67.1K	0.02%	324
2024 Q3	$30.8M	Buy	972,266 +561,404	+137%	+$21.3M	0.02%	292
2024 Q2	$14.4M	Buy	410,862 +154,613	+60%	+$6.12M	0.01%	357
2024 Q1	$11.2M	Buy	+256,249	New	+$11M	0.01%	389

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Jennison Associates's IDYA Position: Q2 2026 in Review

Jennison Associates reduced its IDEAYA Biosciences (IDYA) stake by 2.8% in Q2 2026, selling an estimated $221K and leaving 248,559 shares worth $9.26M. The position accounts for 0.01% of the portfolio, ranked #402.

Jennison Associates first reported a position in IDYA in Q1 2024 and has held it in 7 quarters since. The position peaked at $30.8M in Q3 2024. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

Jennison Associates held 248,559 shares of IDEAYA Biosciences worth $9.26M as of Q2 2026.
Jennison Associates sold 7,205 IDEAYA Biosciences shares in Q2 2026, an estimated $221K.
IDEAYA Biosciences made up 0.01% of Jennison Associates's portfolio in Q2 2026, its #402 holding.
Jennison Associates first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 7 quarters since.
Jennison Associates's IDEAYA Biosciences position peaked at $30.8M in Q3 2024.
286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.